JPRN-UMIN000006537招募中未知
Examination of the optimal lipid-lowering therapy in patients with type 2 diabetes complicated with dyslipidemia - Examination of the optimal lipid-lowering therapy in patients with type 2 diabetes complicated with dyslipidemia
Department of Endocrinology and Metabolism Kyoto Prefectural University of Medicine, Graduate School of Medical Science0 个研究点目标入组 30 人开始时间: 2011年10月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with hypersensitivity against ezetimibe and pravastatin, 2)Patients with severe renal dysfunction and severe hepatic dysfunction, 3)Pregnant women, women who may be pregnant, and breast-feeding women. 4)Patients with drug-induced and familial dyslipidemia, 5)Patients treated with insulin 6)Patients judged by the investigator/ sub investigator to be ineligible for some other reason.
研究者
相似试验
已完成
不适用
Aggressive lipid-lowering treatment approaches for vulnerable plaque in coronary artery with rosuvastatin. -Assessment using angioscopy and intravascular ultrasoundHypercholesterolemiaJPRN-UMIN000003276ALTAIR Study50
已完成
4 期
Randomized trial of Lipid lowering Therapy for Endothelial Function;Statin Monotherapy Compared with Statin/Ezetimibe or Statin/Eicosapentaenoic Acid Combination TherapyJPRN-UMIN000008060Fukuoka wajiro hospital80
已完成
不适用
Randomized controlled trial of the lipid-lowering therapy with rosuvastatin and atorvastatin for the patients with coronary artery disease treated with percutaneous coronary interventiocoronary artery diseaseJPRN-UMIN000014342Hirosaki University Graduate School of Medicine300
已完成
不适用
Effects of Aggressive Lipid Lowering Therapy With Atorvastatin on the Fibrous cap Thickness of Thin-cap Fibroatheroma: Three-Vessel Optical Coherence Tomography and Intravascular Ultrasound StudyAcute Coronary SyndromeJPRN-UMIN000003620Hyogo College of Medicine Cardiovascular Division50
已完成
不适用
The effecs of intensive lipid-lowering therapy on the progression of atherosclerotic kidney diseasechronic kidney diseaseJPRN-UMIN000021356niversity, School of Medicine40